Macitentan Plus Tadalafil Single‐Tablet Combination Therapy in Chinese Patients With Pulmonary Arterial Hypertension: A Subgroup Analysis of the A DUE Study
Sign Up to like & getrecommendations! Published in 2025 at "Pulmonary Circulation"
DOI: 10.1002/pul2.70194
Abstract: ABSTRACT Macitentan 10 mg and tadalafil 40 mg single‐tablet combination therapy (M/T STCT) has been evaluated in the global A DUE study (NCT03904693). Here, we report the results of a subgroup analysis in participants from China. This… read more here.
Keywords: chinese patients; tadalafil single; due study; single tablet ... See more keywords